期刊文献+

高效液相外标法测定人血浆中缬沙坦、氢氯噻嗪浓度

下载PDF
导出
摘要 目的建立测定血浆中缬沙坦、氢氯噻嗪浓度的高效液相外标法。方法采用RP-HPLC法测定血浆中的缬沙坦和氢氯噻嗪,分别用沉淀法和萃取法去除蛋白,荧光检测器和紫外检测器测定,外标法定量。结果缬沙坦的线性范围为0.05~8.00 mg/L(r=0.9999),相对回收率为89.7%~99.7%(n=5),绝对回收率为78.9%~90.7%(n=5),日内精密度RSD为1.1%~3.2%,日间精密度RSD为1.5%~3.9%;氢氯噻嗪的线性范围为2.5~300μg/L(r=0.9995),相对回收率为91.5%~98.4%(n=5),绝对回收率为78.2%~91.5%(n=5);日内精密度RSD为2.1%~7.4%,日间精密度RSD为2.4%~7.7%。结论高效液相外标法具有特异性强、快速、准确的优点,可用于血浆中缬沙坦、氢氯噻嗪的快速测定及人体药动学研究。
出处 《中国医药指南》 2012年第5期76-78,共3页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献13

  • 1方东伟.高效液相色谱法测定复方利血平片中氢氯噻嗪含量[J].中国药业,2005,14(9):51-51. 被引量:5
  • 2赵飞浪,罗楠,袁倚盛,王平.正相高效液相色谱法测定人血浆中的氢氯噻嗪及药动学研究[J].中国药学杂志,1996,31(8):482-484. 被引量:15
  • 3Daneshtalab N, Lewanczuk RZ, Jamali F. High-performance liquid chromatographic analysis of angiotensin Ⅱ receptor antagonist valsartan using a liquid extraction method[J]. J Chronatogr B, 2002,766(6):345 - 349.
  • 4Sechaud R, Graf P, Bigler H. Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteer using a replicated crossover design[J]. lnt J Clin Pharmacol Therap, 2002,40(1) :35 - 40.
  • 5Gonzalez L, Lopez JA, Alonso RM. Fast screening method for the determination of angiotensin Ⅱ receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection[J].J Chromatogr A, 2002,949(1-2) :49 - 60.
  • 6Redalieu E, Tipnis VV, Wagner WE. Determination of plasma hydrochlorothiazide levels in humans [ J ]. Int J Pharm, 200210(246): 199 - 202.
  • 7BURNIER M.Angiotensin Ⅱ tape 1 recepter blockers[J].Circulation,2001,103(6):904 -912.
  • 8CHOBANIAN AV,BAKRIS GL,BLACK HR,et al.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure.[J].JAMA,2003,289 (19):2560-2572.
  • 9COHN JN,TOGNONI G,GLAZER RD,et al.A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure[J].N Engl J Med,2001,345(23):1667-1675.
  • 10KJELDSEN SE,JULIUS S,BRUNNER H,et al.Characteristics of 15 314 hypertensive patients at high coronary risk.The VALUE trial.The Valsartan Antihypertensive Long-term Use Evaluation.[J].Blood Press,2001,10(2):83 -91.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部